EW Q1 2019 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$993M+11.0% YoY

Gross Profit

$754M75.9% margin

Operating Income

$302M30.4% margin

Net Income

$250M25.1% margin

EPS (Diluted)

$0.39

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$58M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$5.5B

Total Liabilities

$2.0B

Stockholders' Equity

$3.4B

Cash & Equivalents

$709M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$993M	$895M	+11.0%
Gross Profit	$754M	$663M	+13.7%
Operating Income	$302M	$265M	+14.0%
Net Income	$250M	$207M	+20.9%

Revenue Segments

Transcatheter Heart Valves

$598M60%

Surgical Heart Valve Therapy

$215M22%

Critical Care

$176M18%

Transcatheter Mitral And Tricuspid Therapies

$4M0%

Geographic Segments

UNITED STATES

$563M57%

Europe

$235M24%

JAPAN

$98M10%

Rest of World

$97M10%